Conclusion Prescriptive peptide therapies, including oral BPC-157, larazotide, KPV, and injectable thymosin beta-4, offer a groundbreaking approach to managing chronic conditions like leaky gut syndrome, IBD, celiac recovery, autoimmune diseases, and MCAS
Fiedor J, Burda K (2014) Potential role of carotenoids as antioxidants in human health and disease
Eli Lily & Big Pharma have worked with V*sa and M*stercard to collude and categorize research peptides as high risk
Spectrochim Acta A Mol Biomol Spectrosc 137:10291038
Huang L, Guo R, Li S, Wu X, Zhang Y, Guo S, Lv Y, Xiao Z, Kang J, Meng J, Zhou P, Ma J, You W, Zhang Y, Yu H, Zhao J, Huang G, Duan Z, Yan Q, Sun W (2024) A multi-kingdom collection of 33,804 reference genomes for the human vaginal microbiome
As growth slows, drugmakers face tougher competition in the lucrative obesity and diabetes treatment market